• Posted: June 4, 2016 Day Two Sessions: ASCO 2016

    The MMRF/MMRC team is spending nearly a week at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting and we are pleased to share with you some...

    READ MORE
  • Posted: June 4, 2016 Day One: ASCO 2016

    American Society of Clinical Oncology (ASCO) 2016, the largest international meeting focused specifically on oncology, opened yesterday. Late in the...

    READ MORE
  • Posted: May 26, 2016 Opposite activation of the Hedgehog pathway in CD138+ plasma cells and...

    Martello M, Remondini D, Borsi E, Santacroce B, Procacci M, Pezzi A, Dico FA, Martinelli G, Zamagni E, Tacchetti P, Pantani L, Testoni N, Marzocchi G, Rocchi...

    READ MORE
  • Posted: May 26, 2016 Phase 1 Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced...

    Harrison SJ, Mainwaring P, Price T, Millward MJ, Padrik P, Underhill CR, Cannell PK, Reich SD, Trikha M, Spencer A. Clin Cancer Res. 2016 Apr 26. pii:...

    READ MORE
  • Posted: May 26, 2016 Minimal residual disease monitoring and immune profiling using second...

    Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, Flores-Montero J, Gutierrez NC, Martín-Ramos ML, Martinez-Lopez J, Ocio EM, Hernandez MT, Teruel...

    READ MORE
  • Posted: May 26, 2016 Marizomib irreversibly inhibits proteasome to overcome compensatory...

    Levin N, Spencer A, Harrison SJ, Chauhan D, Burrows FJ, Anderson KC, Reich SD, Richardson PG, Trikha M. Br J Haematol. 2016 May 9. doi: 10.1111/bjh.14113....

    READ MORE
  • Posted: May 26, 2016 Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a...

    Rodriguez TE, Hari P, Stiff PJ, Smith SE, Sterrenberg D, Vesole DV. Biol Blood Marrow Transplant. 2016 May 7. pii: S1083-8791(16)00190-7. doi:...

    READ MORE
  • Posted: May 26, 2016 Final overall survival results of a randomized trial comparing bortezomib plus...

    Orlowski RZ, Nagler A, Sonneveld P, Bladé J, Hajek R, Spencer A, Robak T, Dmoszynska A, Horvath N, Spicka I, Sutherland HJ, Suvorov AN, Xiu L, Cakana A,...

    READ MORE
  • Posted: May 26, 2016 CHAMPION-1: a phase 1/2 study of weekly carfilzomib and dexamethasone for...

    Berenson JR, Cartmell A, Bessudo A, Lyons RM, Harb W, Tzachanis D, Agajanian R, Boccia R, Coleman M, Moss RA, Rifkin RM, Patel P, Dixon S, Ou Y, Anderl J,...

    READ MORE
  • Posted: May 26, 2016 Clinical efficacy of daratumumab monotherapy in patients with heavily...

    Usmani SZ, Weiss BM, Plesner T, Bahlis NJ, Belch A, Lonial S, Lokhorst HM, Voorhees PM, Richardson PG, Chari A, Sasser AK, Axel A, Feng H, Uhlar CM, Wang J,...

    READ MORE

Page 8/15